Drug Development

Celgene EVP Bagger gets a plum assignment on Trump team

BioCentury picked up a juicy bit of biotech-related presidential campaign news. Quoting sources, BioCentury says that Celgene EVP of corporate affairs Rich Bagger has taken a leave to work on Donald Trump’s transition team. That won’t get any flak from the top team at Celgene, as Executive Chairman Bob Hugin is a committed Republican and delegate pledged to back Trump at the Republican Convention this week.

But Trump may not have been Hugin’s first choice for the nomination.

According the federal election records, Hugin personally contributed $250,000 over the past year to America Leads, a super PAC that had backed New Jersey Governor Chris Christie’s run for the White House.

Bagger also has deep ties with the Republican Party, having served a 2-year stint as chief of staff to Christie. He has also been elected as a state senator in New Jersey, where Celgene is based.

Get Endpoints News in your inbox

News reports for those who discover, develop, and market drugs. Join 16,000+ biopharma pros who read Endpoints News articles by email every day. Free subscription.

Quick Subscribe

You're subscribing to Endpoints News

John Carroll, Editor and Co-Founder

We produce two daily newsletters designed to give you a complete picture of what's important in biopharma.

Early Edition is a skimmable digest of original sources you need to see by ~7:15a ET, and our Main Edition is the daily chronicle of biotech, with every story inside the email ~11:55a ET.
2x/weekdays. Privacy policy